nodes	percent_of_prediction	percent_of_DWPC	metapath
Buspirone—ABCB1—lung cancer	0.168	1	CbGaD
Buspirone—CYP3A5—Gefitinib—lung cancer	0.0303	0.0523	CbGbCtD
Buspirone—CYP3A5—Teniposide—lung cancer	0.0294	0.0507	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0219	0.0377	CbGbCtD
Buspirone—CYP3A7—Paclitaxel—lung cancer	0.0219	0.0377	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0216	0.0372	CbGbCtD
Buspirone—CYP3A7—Irinotecan—lung cancer	0.0216	0.0372	CbGbCtD
Buspirone—ABCB1—Topotecan—lung cancer	0.0216	0.0372	CbGbCtD
Buspirone—ABCB1—Gefitinib—lung cancer	0.0197	0.034	CbGbCtD
Buspirone—CYP2D6—Gefitinib—lung cancer	0.0186	0.032	CbGbCtD
Buspirone—CYP3A5—Crizotinib—lung cancer	0.0186	0.032	CbGbCtD
Buspirone—CYP3A5—Erlotinib—lung cancer	0.0179	0.0309	CbGbCtD
Buspirone—CYP3A5—Paclitaxel—lung cancer	0.0164	0.0283	CbGbCtD
Buspirone—CYP3A5—Irinotecan—lung cancer	0.0162	0.0279	CbGbCtD
Buspirone—CYP3A7—Docetaxel—lung cancer	0.0158	0.0273	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0158	0.0273	CbGbCtD
Buspirone—ABCB1—Vinorelbine—lung cancer	0.0152	0.0262	CbGbCtD
Buspirone—CYP2D6—Vinorelbine—lung cancer	0.0143	0.0247	CbGbCtD
Buspirone—CYP3A5—Etoposide—lung cancer	0.013	0.0224	CbGbCtD
Buspirone—CYP3A4—Topotecan—lung cancer	0.0129	0.0223	CbGbCtD
Buspirone—ABCB1—Crizotinib—lung cancer	0.0121	0.0208	CbGbCtD
Buspirone—CYP3A5—Docetaxel—lung cancer	0.0119	0.0204	CbGbCtD
Buspirone—CYP3A4—Gefitinib—lung cancer	0.0118	0.0204	CbGbCtD
Buspirone—ABCB1—Gemcitabine—lung cancer	0.0118	0.0204	CbGbCtD
Buspirone—ABCB1—Erlotinib—lung cancer	0.0117	0.0201	CbGbCtD
Buspirone—CYP3A4—Teniposide—lung cancer	0.0115	0.0198	CbGbCtD
Buspirone—CYP2D6—Erlotinib—lung cancer	0.011	0.0189	CbGbCtD
Buspirone—ABCB1—Paclitaxel—lung cancer	0.0107	0.0184	CbGbCtD
Buspirone—ABCB1—Irinotecan—lung cancer	0.0105	0.0182	CbGbCtD
Buspirone—ABCB1—Vinblastine—lung cancer	0.00937	0.0161	CbGbCtD
Buspirone—CYP3A4—Vinorelbine—lung cancer	0.00911	0.0157	CbGbCtD
Buspirone—CYP2D6—Vinblastine—lung cancer	0.00883	0.0152	CbGbCtD
Buspirone—ABCB1—Cisplatin—lung cancer	0.00859	0.0148	CbGbCtD
Buspirone—ABCB1—Etoposide—lung cancer	0.00844	0.0145	CbGbCtD
Buspirone—ABCB1—Docetaxel—lung cancer	0.00772	0.0133	CbGbCtD
Buspirone—CYP3A4—Crizotinib—lung cancer	0.00725	0.0125	CbGbCtD
Buspirone—CYP3A4—Erlotinib—lung cancer	0.00699	0.012	CbGbCtD
Buspirone—CYP3A4—Paclitaxel—lung cancer	0.0064	0.011	CbGbCtD
Buspirone—CYP3A4—Irinotecan—lung cancer	0.00631	0.0109	CbGbCtD
Buspirone—ABCB1—Doxorubicin—lung cancer	0.00576	0.00992	CbGbCtD
Buspirone—CYP3A4—Vinblastine—lung cancer	0.00561	0.00967	CbGbCtD
Buspirone—ABCB1—Methotrexate—lung cancer	0.00558	0.00961	CbGbCtD
Buspirone—CYP2D6—Doxorubicin—lung cancer	0.00543	0.00935	CbGbCtD
Buspirone—CYP3A4—Etoposide—lung cancer	0.00506	0.00872	CbGbCtD
Buspirone—CYP3A4—Docetaxel—lung cancer	0.00463	0.00797	CbGbCtD
Buspirone—CYP3A4—Doxorubicin—lung cancer	0.00345	0.00594	CbGbCtD
Buspirone—HTR2A—phrenic nerve—lung cancer	0.00276	0.482	CbGeAlD
Buspirone—HTR2A—pulmonary artery—lung cancer	0.001	0.175	CbGeAlD
Buspirone—DRD2—respiratory system—lung cancer	0.000255	0.0446	CbGeAlD
Buspirone—CYP3A5—respiratory system—lung cancer	0.000208	0.0363	CbGeAlD
Buspirone—HTR2A—respiratory system—lung cancer	0.000168	0.0294	CbGeAlD
Buspirone—HTR2B—lung—lung cancer	0.000167	0.0293	CbGeAlD
Buspirone—HTR2A—epithelium—lung cancer	0.000141	0.0246	CbGeAlD
Buspirone—DRD2—lung—lung cancer	0.000136	0.0237	CbGeAlD
Buspirone—HTR2A—trachea—lung cancer	0.000124	0.0218	CbGeAlD
Buspirone—HTR2B—lymph node—lung cancer	0.000114	0.02	CbGeAlD
Buspirone—Thrombocytopenia—Paclitaxel—lung cancer	0.000113	0.00067	CcSEcCtD
Buspirone—Tachycardia—Paclitaxel—lung cancer	0.000113	0.000668	CcSEcCtD
Buspirone—Anorexia—Etoposide—lung cancer	0.000112	0.000665	CcSEcCtD
Buspirone—Body temperature increased—Irinotecan—lung cancer	0.000112	0.000663	CcSEcCtD
Buspirone—Decreased appetite—Cisplatin—lung cancer	0.000112	0.000662	CcSEcCtD
Buspirone—Hyperhidrosis—Paclitaxel—lung cancer	0.000112	0.000662	CcSEcCtD
Buspirone—Gastrointestinal disorder—Cisplatin—lung cancer	0.000111	0.000658	CcSEcCtD
Buspirone—Drowsiness—Methotrexate—lung cancer	0.000111	0.000656	CcSEcCtD
Buspirone—Depression—Methotrexate—lung cancer	0.00011	0.000654	CcSEcCtD
Buspirone—ABCB1—respiratory system—lung cancer	0.00011	0.0193	CbGeAlD
Buspirone—Anorexia—Paclitaxel—lung cancer	0.00011	0.000652	CcSEcCtD
Buspirone—CYP3A5—lung—lung cancer	0.00011	0.0193	CbGeAlD
Buspirone—Hypotension—Etoposide—lung cancer	0.00011	0.000652	CcSEcCtD
Buspirone—Pain—Cisplatin—lung cancer	0.00011	0.000652	CcSEcCtD
Buspirone—Muscular weakness—Doxorubicin—lung cancer	0.00011	0.00065	CcSEcCtD
Buspirone—Vomiting—Vinorelbine—lung cancer	0.000109	0.000647	CcSEcCtD
Buspirone—Body temperature increased—Gemcitabine—lung cancer	0.000109	0.000646	CcSEcCtD
Buspirone—Rash—Vinorelbine—lung cancer	0.000108	0.000642	CcSEcCtD
Buspirone—Dermatitis—Vinorelbine—lung cancer	0.000108	0.000641	CcSEcCtD
Buspirone—Hypotension—Paclitaxel—lung cancer	0.000108	0.000639	CcSEcCtD
Buspirone—Headache—Vinorelbine—lung cancer	0.000108	0.000637	CcSEcCtD
Buspirone—Syncope—Docetaxel—lung cancer	0.000108	0.000637	CcSEcCtD
Buspirone—Conjunctivitis—Methotrexate—lung cancer	0.000108	0.000637	CcSEcCtD
Buspirone—Leukopenia—Docetaxel—lung cancer	0.000108	0.000636	CcSEcCtD
Buspirone—Eosinophilia—Doxorubicin—lung cancer	0.000107	0.00063	CcSEcCtD
Buspirone—Sweating—Methotrexate—lung cancer	0.000106	0.000628	CcSEcCtD
Buspirone—Palpitations—Docetaxel—lung cancer	0.000106	0.000628	CcSEcCtD
Buspirone—Feeling abnormal—Cisplatin—lung cancer	0.000106	0.000628	CcSEcCtD
Buspirone—Paraesthesia—Etoposide—lung cancer	0.000106	0.000627	CcSEcCtD
Buspirone—Loss of consciousness—Docetaxel—lung cancer	0.000106	0.000625	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000105	0.000624	CcSEcCtD
Buspirone—Dyspnoea—Etoposide—lung cancer	0.000105	0.000622	CcSEcCtD
Buspirone—Somnolence—Etoposide—lung cancer	0.000105	0.000621	CcSEcCtD
Buspirone—Insomnia—Paclitaxel—lung cancer	0.000105	0.000619	CcSEcCtD
Buspirone—Epistaxis—Methotrexate—lung cancer	0.000105	0.000618	CcSEcCtD
Buspirone—Hypersensitivity—Irinotecan—lung cancer	0.000105	0.000618	CcSEcCtD
Buspirone—Convulsion—Docetaxel—lung cancer	0.000104	0.000616	CcSEcCtD
Buspirone—Paraesthesia—Paclitaxel—lung cancer	0.000104	0.000615	CcSEcCtD
Buspirone—Hypertension—Docetaxel—lung cancer	0.000104	0.000614	CcSEcCtD
Buspirone—Dyspnoea—Paclitaxel—lung cancer	0.000103	0.00061	CcSEcCtD
Buspirone—Somnolence—Paclitaxel—lung cancer	0.000103	0.000608	CcSEcCtD
Buspirone—Decreased appetite—Etoposide—lung cancer	0.000103	0.000607	CcSEcCtD
Buspirone—Chest pain—Docetaxel—lung cancer	0.000102	0.000605	CcSEcCtD
Buspirone—Myalgia—Docetaxel—lung cancer	0.000102	0.000605	CcSEcCtD
Buspirone—Arthralgia—Docetaxel—lung cancer	0.000102	0.000605	CcSEcCtD
Buspirone—Nausea—Vinorelbine—lung cancer	0.000102	0.000604	CcSEcCtD
Buspirone—Gastrointestinal disorder—Etoposide—lung cancer	0.000102	0.000603	CcSEcCtD
Buspirone—Dyspepsia—Paclitaxel—lung cancer	0.000102	0.000602	CcSEcCtD
Buspirone—Body temperature increased—Cisplatin—lung cancer	0.000102	0.000602	CcSEcCtD
Buspirone—Asthenia—Irinotecan—lung cancer	0.000102	0.000602	CcSEcCtD
Buspirone—Fatigue—Etoposide—lung cancer	0.000102	0.000602	CcSEcCtD
Buspirone—Constipation—Etoposide—lung cancer	0.000101	0.000597	CcSEcCtD
Buspirone—Pain—Etoposide—lung cancer	0.000101	0.000597	CcSEcCtD
Buspirone—Dysuria—Doxorubicin—lung cancer	0.000101	0.000595	CcSEcCtD
Buspirone—Decreased appetite—Paclitaxel—lung cancer	0.000101	0.000595	CcSEcCtD
Buspirone—Dry mouth—Docetaxel—lung cancer	0.0001	0.000592	CcSEcCtD
Buspirone—Haemoglobin—Methotrexate—lung cancer	0.0001	0.000591	CcSEcCtD
Buspirone—Gastrointestinal disorder—Paclitaxel—lung cancer	9.99e-05	0.000591	CcSEcCtD
Buspirone—Fatigue—Paclitaxel—lung cancer	9.97e-05	0.00059	CcSEcCtD
Buspirone—Haemorrhage—Methotrexate—lung cancer	9.95e-05	0.000588	CcSEcCtD
Buspirone—Pollakiuria—Doxorubicin—lung cancer	9.94e-05	0.000588	CcSEcCtD
Buspirone—Asthenia—Gemcitabine—lung cancer	9.91e-05	0.000586	CcSEcCtD
Buspirone—Pain—Paclitaxel—lung cancer	9.89e-05	0.000585	CcSEcCtD
Buspirone—Constipation—Paclitaxel—lung cancer	9.89e-05	0.000585	CcSEcCtD
Buspirone—Confusional state—Docetaxel—lung cancer	9.89e-05	0.000585	CcSEcCtD
Buspirone—Oedema—Docetaxel—lung cancer	9.81e-05	0.00058	CcSEcCtD
Buspirone—Weight increased—Doxorubicin—lung cancer	9.79e-05	0.000579	CcSEcCtD
Buspirone—Pruritus—Gemcitabine—lung cancer	9.78e-05	0.000578	CcSEcCtD
Buspirone—Weight decreased—Doxorubicin—lung cancer	9.74e-05	0.000576	CcSEcCtD
Buspirone—Feeling abnormal—Etoposide—lung cancer	9.72e-05	0.000575	CcSEcCtD
Buspirone—Diarrhoea—Irinotecan—lung cancer	9.71e-05	0.000574	CcSEcCtD
Buspirone—Shock—Docetaxel—lung cancer	9.65e-05	0.000571	CcSEcCtD
Buspirone—Thrombocytopenia—Docetaxel—lung cancer	9.6e-05	0.000568	CcSEcCtD
Buspirone—Drowsiness—Doxorubicin—lung cancer	9.6e-05	0.000568	CcSEcCtD
Buspirone—Tachycardia—Docetaxel—lung cancer	9.57e-05	0.000566	CcSEcCtD
Buspirone—Feeling abnormal—Paclitaxel—lung cancer	9.53e-05	0.000564	CcSEcCtD
Buspirone—Hypersensitivity—Cisplatin—lung cancer	9.49e-05	0.000561	CcSEcCtD
Buspirone—Diarrhoea—Gemcitabine—lung cancer	9.45e-05	0.000559	CcSEcCtD
Buspirone—Dizziness—Irinotecan—lung cancer	9.38e-05	0.000555	CcSEcCtD
Buspirone—Urticaria—Etoposide—lung cancer	9.37e-05	0.000554	CcSEcCtD
Buspirone—Anorexia—Docetaxel—lung cancer	9.35e-05	0.000553	CcSEcCtD
Buspirone—Body temperature increased—Etoposide—lung cancer	9.33e-05	0.000552	CcSEcCtD
Buspirone—Conjunctivitis—Doxorubicin—lung cancer	9.33e-05	0.000552	CcSEcCtD
Buspirone—Tinnitus—Methotrexate—lung cancer	9.28e-05	0.000549	CcSEcCtD
Buspirone—Asthenia—Cisplatin—lung cancer	9.24e-05	0.000547	CcSEcCtD
Buspirone—ABCB1—epithelium—lung cancer	9.22e-05	0.0161	CbGeAlD
Buspirone—Sweating—Doxorubicin—lung cancer	9.2e-05	0.000544	CcSEcCtD
Buspirone—Urticaria—Paclitaxel—lung cancer	9.19e-05	0.000544	CcSEcCtD
Buspirone—Hypotension—Docetaxel—lung cancer	9.16e-05	0.000542	CcSEcCtD
Buspirone—Body temperature increased—Paclitaxel—lung cancer	9.15e-05	0.000541	CcSEcCtD
Buspirone—Epistaxis—Doxorubicin—lung cancer	9.05e-05	0.000535	CcSEcCtD
Buspirone—Vomiting—Irinotecan—lung cancer	9.02e-05	0.000534	CcSEcCtD
Buspirone—Rash—Irinotecan—lung cancer	8.94e-05	0.000529	CcSEcCtD
Buspirone—HTR2A—lung—lung cancer	8.94e-05	0.0156	CbGeAlD
Buspirone—Dermatitis—Irinotecan—lung cancer	8.94e-05	0.000529	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Docetaxel—lung cancer	8.93e-05	0.000528	CcSEcCtD
Buspirone—Chills—Methotrexate—lung cancer	8.93e-05	0.000528	CcSEcCtD
Buspirone—Headache—Irinotecan—lung cancer	8.89e-05	0.000526	CcSEcCtD
Buspirone—Insomnia—Docetaxel—lung cancer	8.87e-05	0.000525	CcSEcCtD
Buspirone—Diarrhoea—Cisplatin—lung cancer	8.81e-05	0.000521	CcSEcCtD
Buspirone—Paraesthesia—Docetaxel—lung cancer	8.81e-05	0.000521	CcSEcCtD
Buspirone—Alopecia—Methotrexate—lung cancer	8.79e-05	0.00052	CcSEcCtD
Buspirone—Vomiting—Gemcitabine—lung cancer	8.79e-05	0.00052	CcSEcCtD
Buspirone—Bradycardia—Doxorubicin—lung cancer	8.77e-05	0.000519	CcSEcCtD
Buspirone—Dyspnoea—Docetaxel—lung cancer	8.74e-05	0.000517	CcSEcCtD
Buspirone—Somnolence—Docetaxel—lung cancer	8.72e-05	0.000516	CcSEcCtD
Buspirone—Rash—Gemcitabine—lung cancer	8.71e-05	0.000515	CcSEcCtD
Buspirone—Dermatitis—Gemcitabine—lung cancer	8.7e-05	0.000515	CcSEcCtD
Buspirone—Hypersensitivity—Etoposide—lung cancer	8.69e-05	0.000514	CcSEcCtD
Buspirone—Erythema—Methotrexate—lung cancer	8.66e-05	0.000512	CcSEcCtD
Buspirone—Haemoglobin—Doxorubicin—lung cancer	8.66e-05	0.000512	CcSEcCtD
Buspirone—Headache—Gemcitabine—lung cancer	8.66e-05	0.000512	CcSEcCtD
Buspirone—Dyspepsia—Docetaxel—lung cancer	8.63e-05	0.000511	CcSEcCtD
Buspirone—Haemorrhage—Doxorubicin—lung cancer	8.61e-05	0.00051	CcSEcCtD
Buspirone—Hypoaesthesia—Doxorubicin—lung cancer	8.57e-05	0.000507	CcSEcCtD
Buspirone—Decreased appetite—Docetaxel—lung cancer	8.52e-05	0.000504	CcSEcCtD
Buspirone—Hypersensitivity—Paclitaxel—lung cancer	8.52e-05	0.000504	CcSEcCtD
Buspirone—Dysgeusia—Methotrexate—lung cancer	8.48e-05	0.000502	CcSEcCtD
Buspirone—Gastrointestinal disorder—Docetaxel—lung cancer	8.47e-05	0.000501	CcSEcCtD
Buspirone—Asthenia—Etoposide—lung cancer	8.47e-05	0.000501	CcSEcCtD
Buspirone—Fatigue—Docetaxel—lung cancer	8.45e-05	0.0005	CcSEcCtD
Buspirone—Nausea—Irinotecan—lung cancer	8.43e-05	0.000498	CcSEcCtD
Buspirone—Pain—Docetaxel—lung cancer	8.39e-05	0.000496	CcSEcCtD
Buspirone—Constipation—Docetaxel—lung cancer	8.39e-05	0.000496	CcSEcCtD
Buspirone—Pruritus—Etoposide—lung cancer	8.35e-05	0.000494	CcSEcCtD
Buspirone—Asthenia—Paclitaxel—lung cancer	8.3e-05	0.000491	CcSEcCtD
Buspirone—Nausea—Gemcitabine—lung cancer	8.21e-05	0.000486	CcSEcCtD
Buspirone—Vomiting—Cisplatin—lung cancer	8.19e-05	0.000484	CcSEcCtD
Buspirone—Pruritus—Paclitaxel—lung cancer	8.18e-05	0.000484	CcSEcCtD
Buspirone—Vision blurred—Methotrexate—lung cancer	8.16e-05	0.000483	CcSEcCtD
Buspirone—ABCB1—trachea—lung cancer	8.15e-05	0.0143	CbGeAlD
Buspirone—Rash—Cisplatin—lung cancer	8.12e-05	0.00048	CcSEcCtD
Buspirone—Dermatitis—Cisplatin—lung cancer	8.11e-05	0.00048	CcSEcCtD
Buspirone—Feeling abnormal—Docetaxel—lung cancer	8.08e-05	0.000478	CcSEcCtD
Buspirone—Diarrhoea—Etoposide—lung cancer	8.07e-05	0.000478	CcSEcCtD
Buspirone—Ill-defined disorder—Methotrexate—lung cancer	8.03e-05	0.000475	CcSEcCtD
Buspirone—Tinnitus—Doxorubicin—lung cancer	8.03e-05	0.000475	CcSEcCtD
Buspirone—Flushing—Doxorubicin—lung cancer	7.99e-05	0.000473	CcSEcCtD
Buspirone—Diarrhoea—Paclitaxel—lung cancer	7.92e-05	0.000468	CcSEcCtD
Buspirone—Malaise—Methotrexate—lung cancer	7.81e-05	0.000462	CcSEcCtD
Buspirone—Dizziness—Etoposide—lung cancer	7.8e-05	0.000462	CcSEcCtD
Buspirone—Vertigo—Methotrexate—lung cancer	7.78e-05	0.00046	CcSEcCtD
Buspirone—Body temperature increased—Docetaxel—lung cancer	7.75e-05	0.000459	CcSEcCtD
Buspirone—Leukopenia—Methotrexate—lung cancer	7.75e-05	0.000459	CcSEcCtD
Buspirone—Chills—Doxorubicin—lung cancer	7.73e-05	0.000457	CcSEcCtD
Buspirone—Dizziness—Paclitaxel—lung cancer	7.65e-05	0.000453	CcSEcCtD
Buspirone—Nausea—Cisplatin—lung cancer	7.65e-05	0.000453	CcSEcCtD
Buspirone—Alopecia—Doxorubicin—lung cancer	7.61e-05	0.00045	CcSEcCtD
Buspirone—Convulsion—Methotrexate—lung cancer	7.5e-05	0.000444	CcSEcCtD
Buspirone—Vomiting—Etoposide—lung cancer	7.5e-05	0.000444	CcSEcCtD
Buspirone—Erythema—Doxorubicin—lung cancer	7.5e-05	0.000444	CcSEcCtD
Buspirone—Rash—Etoposide—lung cancer	7.44e-05	0.00044	CcSEcCtD
Buspirone—Dermatitis—Etoposide—lung cancer	7.43e-05	0.00044	CcSEcCtD
Buspirone—Headache—Etoposide—lung cancer	7.39e-05	0.000437	CcSEcCtD
Buspirone—Flatulence—Doxorubicin—lung cancer	7.39e-05	0.000437	CcSEcCtD
Buspirone—Chest pain—Methotrexate—lung cancer	7.37e-05	0.000436	CcSEcCtD
Buspirone—Arthralgia—Methotrexate—lung cancer	7.37e-05	0.000436	CcSEcCtD
Buspirone—Myalgia—Methotrexate—lung cancer	7.37e-05	0.000436	CcSEcCtD
Buspirone—Tension—Doxorubicin—lung cancer	7.36e-05	0.000435	CcSEcCtD
Buspirone—Vomiting—Paclitaxel—lung cancer	7.36e-05	0.000435	CcSEcCtD
Buspirone—Dysgeusia—Doxorubicin—lung cancer	7.34e-05	0.000434	CcSEcCtD
Buspirone—Rash—Paclitaxel—lung cancer	7.29e-05	0.000431	CcSEcCtD
Buspirone—Dermatitis—Paclitaxel—lung cancer	7.29e-05	0.000431	CcSEcCtD
Buspirone—Discomfort—Methotrexate—lung cancer	7.28e-05	0.000431	CcSEcCtD
Buspirone—Nervousness—Doxorubicin—lung cancer	7.28e-05	0.000431	CcSEcCtD
Buspirone—Headache—Paclitaxel—lung cancer	7.25e-05	0.000429	CcSEcCtD
Buspirone—Hypersensitivity—Docetaxel—lung cancer	7.22e-05	0.000427	CcSEcCtD
Buspirone—Muscle spasms—Doxorubicin—lung cancer	7.21e-05	0.000426	CcSEcCtD
Buspirone—Confusional state—Methotrexate—lung cancer	7.13e-05	0.000422	CcSEcCtD
Buspirone—Vision blurred—Doxorubicin—lung cancer	7.07e-05	0.000418	CcSEcCtD
Buspirone—Asthenia—Docetaxel—lung cancer	7.04e-05	0.000416	CcSEcCtD
Buspirone—Nausea—Etoposide—lung cancer	7.01e-05	0.000415	CcSEcCtD
Buspirone—Ill-defined disorder—Doxorubicin—lung cancer	6.96e-05	0.000412	CcSEcCtD
Buspirone—Pruritus—Docetaxel—lung cancer	6.94e-05	0.00041	CcSEcCtD
Buspirone—Thrombocytopenia—Methotrexate—lung cancer	6.92e-05	0.000409	CcSEcCtD
Buspirone—Agitation—Doxorubicin—lung cancer	6.89e-05	0.000408	CcSEcCtD
Buspirone—Nausea—Paclitaxel—lung cancer	6.87e-05	0.000406	CcSEcCtD
Buspirone—Hyperhidrosis—Methotrexate—lung cancer	6.83e-05	0.000404	CcSEcCtD
Buspirone—Malaise—Doxorubicin—lung cancer	6.76e-05	0.0004	CcSEcCtD
Buspirone—Vertigo—Doxorubicin—lung cancer	6.74e-05	0.000399	CcSEcCtD
Buspirone—Anorexia—Methotrexate—lung cancer	6.74e-05	0.000399	CcSEcCtD
Buspirone—Syncope—Doxorubicin—lung cancer	6.72e-05	0.000398	CcSEcCtD
Buspirone—Leukopenia—Doxorubicin—lung cancer	6.71e-05	0.000397	CcSEcCtD
Buspirone—Diarrhoea—Docetaxel—lung cancer	6.71e-05	0.000397	CcSEcCtD
Buspirone—Palpitations—Doxorubicin—lung cancer	6.63e-05	0.000392	CcSEcCtD
Buspirone—Hypotension—Methotrexate—lung cancer	6.6e-05	0.000391	CcSEcCtD
Buspirone—Loss of consciousness—Doxorubicin—lung cancer	6.59e-05	0.00039	CcSEcCtD
Buspirone—Convulsion—Doxorubicin—lung cancer	6.5e-05	0.000384	CcSEcCtD
Buspirone—Dizziness—Docetaxel—lung cancer	6.48e-05	0.000384	CcSEcCtD
Buspirone—Hypertension—Doxorubicin—lung cancer	6.47e-05	0.000383	CcSEcCtD
Buspirone—ABCB1—bone marrow—lung cancer	6.47e-05	0.0113	CbGeAlD
Buspirone—Musculoskeletal discomfort—Methotrexate—lung cancer	6.44e-05	0.000381	CcSEcCtD
Buspirone—Insomnia—Methotrexate—lung cancer	6.39e-05	0.000378	CcSEcCtD
Buspirone—Arthralgia—Doxorubicin—lung cancer	6.38e-05	0.000378	CcSEcCtD
Buspirone—Chest pain—Doxorubicin—lung cancer	6.38e-05	0.000378	CcSEcCtD
Buspirone—Myalgia—Doxorubicin—lung cancer	6.38e-05	0.000378	CcSEcCtD
Buspirone—Paraesthesia—Methotrexate—lung cancer	6.35e-05	0.000375	CcSEcCtD
Buspirone—Discomfort—Doxorubicin—lung cancer	6.31e-05	0.000373	CcSEcCtD
Buspirone—Dyspnoea—Methotrexate—lung cancer	6.3e-05	0.000373	CcSEcCtD
Buspirone—Somnolence—Methotrexate—lung cancer	6.28e-05	0.000372	CcSEcCtD
Buspirone—Dry mouth—Doxorubicin—lung cancer	6.24e-05	0.000369	CcSEcCtD
Buspirone—Vomiting—Docetaxel—lung cancer	6.23e-05	0.000369	CcSEcCtD
Buspirone—Dyspepsia—Methotrexate—lung cancer	6.22e-05	0.000368	CcSEcCtD
Buspirone—Rash—Docetaxel—lung cancer	6.18e-05	0.000366	CcSEcCtD
Buspirone—Dermatitis—Docetaxel—lung cancer	6.18e-05	0.000365	CcSEcCtD
Buspirone—Confusional state—Doxorubicin—lung cancer	6.17e-05	0.000365	CcSEcCtD
Buspirone—Decreased appetite—Methotrexate—lung cancer	6.14e-05	0.000363	CcSEcCtD
Buspirone—Headache—Docetaxel—lung cancer	6.14e-05	0.000363	CcSEcCtD
Buspirone—Oedema—Doxorubicin—lung cancer	6.12e-05	0.000362	CcSEcCtD
Buspirone—Gastrointestinal disorder—Methotrexate—lung cancer	6.1e-05	0.000361	CcSEcCtD
Buspirone—Fatigue—Methotrexate—lung cancer	6.09e-05	0.00036	CcSEcCtD
Buspirone—Pain—Methotrexate—lung cancer	6.04e-05	0.000358	CcSEcCtD
Buspirone—Shock—Doxorubicin—lung cancer	6.02e-05	0.000356	CcSEcCtD
Buspirone—Thrombocytopenia—Doxorubicin—lung cancer	5.99e-05	0.000354	CcSEcCtD
Buspirone—Tachycardia—Doxorubicin—lung cancer	5.97e-05	0.000353	CcSEcCtD
Buspirone—Hyperhidrosis—Doxorubicin—lung cancer	5.92e-05	0.00035	CcSEcCtD
Buspirone—ABCB1—lung—lung cancer	5.86e-05	0.0102	CbGeAlD
Buspirone—Anorexia—Doxorubicin—lung cancer	5.83e-05	0.000345	CcSEcCtD
Buspirone—Nausea—Docetaxel—lung cancer	5.82e-05	0.000345	CcSEcCtD
Buspirone—Feeling abnormal—Methotrexate—lung cancer	5.82e-05	0.000345	CcSEcCtD
Buspirone—Hypotension—Doxorubicin—lung cancer	5.72e-05	0.000338	CcSEcCtD
Buspirone—Urticaria—Methotrexate—lung cancer	5.61e-05	0.000332	CcSEcCtD
Buspirone—Body temperature increased—Methotrexate—lung cancer	5.59e-05	0.00033	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.58e-05	0.00033	CcSEcCtD
Buspirone—Insomnia—Doxorubicin—lung cancer	5.54e-05	0.000327	CcSEcCtD
Buspirone—Paraesthesia—Doxorubicin—lung cancer	5.5e-05	0.000325	CcSEcCtD
Buspirone—Dyspnoea—Doxorubicin—lung cancer	5.46e-05	0.000323	CcSEcCtD
Buspirone—Somnolence—Doxorubicin—lung cancer	5.44e-05	0.000322	CcSEcCtD
Buspirone—Dyspepsia—Doxorubicin—lung cancer	5.39e-05	0.000319	CcSEcCtD
Buspirone—Decreased appetite—Doxorubicin—lung cancer	5.32e-05	0.000315	CcSEcCtD
Buspirone—Gastrointestinal disorder—Doxorubicin—lung cancer	5.28e-05	0.000313	CcSEcCtD
Buspirone—Fatigue—Doxorubicin—lung cancer	5.28e-05	0.000312	CcSEcCtD
Buspirone—Pain—Doxorubicin—lung cancer	5.23e-05	0.00031	CcSEcCtD
Buspirone—Constipation—Doxorubicin—lung cancer	5.23e-05	0.00031	CcSEcCtD
Buspirone—Hypersensitivity—Methotrexate—lung cancer	5.21e-05	0.000308	CcSEcCtD
Buspirone—Asthenia—Methotrexate—lung cancer	5.07e-05	0.0003	CcSEcCtD
Buspirone—Feeling abnormal—Doxorubicin—lung cancer	5.04e-05	0.000298	CcSEcCtD
Buspirone—Pruritus—Methotrexate—lung cancer	5e-05	0.000296	CcSEcCtD
Buspirone—Urticaria—Doxorubicin—lung cancer	4.86e-05	0.000288	CcSEcCtD
Buspirone—Body temperature increased—Doxorubicin—lung cancer	4.84e-05	0.000286	CcSEcCtD
Buspirone—Diarrhoea—Methotrexate—lung cancer	4.84e-05	0.000286	CcSEcCtD
Buspirone—Dizziness—Methotrexate—lung cancer	4.67e-05	0.000276	CcSEcCtD
Buspirone—Hypersensitivity—Doxorubicin—lung cancer	4.51e-05	0.000267	CcSEcCtD
Buspirone—Vomiting—Methotrexate—lung cancer	4.49e-05	0.000266	CcSEcCtD
Buspirone—Rash—Methotrexate—lung cancer	4.46e-05	0.000264	CcSEcCtD
Buspirone—Dermatitis—Methotrexate—lung cancer	4.45e-05	0.000263	CcSEcCtD
Buspirone—Headache—Methotrexate—lung cancer	4.43e-05	0.000262	CcSEcCtD
Buspirone—Asthenia—Doxorubicin—lung cancer	4.39e-05	0.00026	CcSEcCtD
Buspirone—Pruritus—Doxorubicin—lung cancer	4.33e-05	0.000256	CcSEcCtD
Buspirone—Nausea—Methotrexate—lung cancer	4.2e-05	0.000248	CcSEcCtD
Buspirone—Diarrhoea—Doxorubicin—lung cancer	4.19e-05	0.000248	CcSEcCtD
Buspirone—Dizziness—Doxorubicin—lung cancer	4.05e-05	0.000239	CcSEcCtD
Buspirone—ABCB1—lymph node—lung cancer	4.01e-05	0.007	CbGeAlD
Buspirone—Vomiting—Doxorubicin—lung cancer	3.89e-05	0.00023	CcSEcCtD
Buspirone—Rash—Doxorubicin—lung cancer	3.86e-05	0.000228	CcSEcCtD
Buspirone—Dermatitis—Doxorubicin—lung cancer	3.86e-05	0.000228	CcSEcCtD
Buspirone—Headache—Doxorubicin—lung cancer	3.83e-05	0.000227	CcSEcCtD
Buspirone—Nausea—Doxorubicin—lung cancer	3.64e-05	0.000215	CcSEcCtD
Buspirone—ABCB1—Metabolism—GSTM1—lung cancer	5.73e-06	7.47e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CAT—lung cancer	5.71e-06	7.46e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ENO2—lung cancer	5.71e-06	7.45e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—HPGDS—lung cancer	5.71e-06	7.45e-05	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—PIK3CA—lung cancer	5.7e-06	7.43e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CASP3—lung cancer	5.69e-06	7.42e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EGF—lung cancer	5.68e-06	7.41e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IL2—lung cancer	5.68e-06	7.41e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.67e-06	7.41e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—APC—lung cancer	5.65e-06	7.38e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CG—lung cancer	5.65e-06	7.38e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—KIT—lung cancer	5.65e-06	7.38e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—NRAS—lung cancer	5.65e-06	7.38e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—IL6—lung cancer	5.65e-06	7.37e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CG—lung cancer	5.63e-06	7.35e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—KRAS—lung cancer	5.63e-06	7.35e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EGF—lung cancer	5.59e-06	7.29e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ABCB1—lung cancer	5.56e-06	7.25e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GSTT1—lung cancer	5.54e-06	7.23e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CCND1—lung cancer	5.53e-06	7.22e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CXCL8—lung cancer	5.53e-06	7.21e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—JUN—lung cancer	5.52e-06	7.21e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—MAPK3—lung cancer	5.5e-06	7.18e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—HRAS—lung cancer	5.49e-06	7.17e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GCLC—lung cancer	5.47e-06	7.15e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP2A6—lung cancer	5.47e-06	7.15e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—POMC—lung cancer	5.47e-06	7.14e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—TYMS—lung cancer	5.46e-06	7.13e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CYP1A1—lung cancer	5.43e-06	7.09e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—MAPK3—lung cancer	5.41e-06	7.06e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—BRAF—lung cancer	5.4e-06	7.05e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—GSTM1—lung cancer	5.4e-06	7.04e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ERCC2—lung cancer	5.38e-06	7.03e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—POMC—lung cancer	5.38e-06	7.02e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MMP9—lung cancer	5.37e-06	7.01e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—POMC—lung cancer	5.36e-06	7e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—CDKN1A—lung cancer	5.35e-06	6.99e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PTEN—lung cancer	5.34e-06	6.97e-05	CbGpPWpGaD
Buspirone—DRD3—GPCR downstream signaling—AKT1—lung cancer	5.34e-06	6.97e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IL6R—lung cancer	5.33e-06	6.96e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CREBBP—lung cancer	5.33e-06	6.95e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—BRAF—lung cancer	5.31e-06	6.93e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CASP3—lung cancer	5.29e-06	6.9e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IL2—lung cancer	5.28e-06	6.89e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—IL6—lung cancer	5.26e-06	6.86e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IL6R—lung cancer	5.25e-06	6.85e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CREBBP—lung cancer	5.24e-06	6.84e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—EGFR—lung cancer	5.23e-06	6.83e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—CREBBP—lung cancer	5.22e-06	6.82e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling by GPCR—AKT1—lung cancer	5.21e-06	6.8e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ENO1—lung cancer	5.19e-06	6.77e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—PIK3CA—lung cancer	5.17e-06	6.75e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PTEN—lung cancer	5.16e-06	6.74e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MDM2—lung cancer	5.15e-06	6.72e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CCND1—lung cancer	5.15e-06	6.72e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—EGFR—lung cancer	5.15e-06	6.72e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—JUN—lung cancer	5.14e-06	6.71e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—RAF1—lung cancer	5.13e-06	6.7e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CYP1A1—lung cancer	5.12e-06	6.68e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—EP300—lung cancer	5.09e-06	6.65e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MAP2K1—lung cancer	5.08e-06	6.63e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—ERBB2—lung cancer	5.08e-06	6.63e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ERCC2—lung cancer	5.07e-06	6.62e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CD—lung cancer	5.05e-06	6.59e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CB—lung cancer	5.01e-06	6.54e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MTOR—lung cancer	5.01e-06	6.54e-05	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—PIK3CA—lung cancer	5e-06	6.53e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MAP2K1—lung cancer	5e-06	6.53e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MMP9—lung cancer	5e-06	6.52e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—CDKN1A—lung cancer	4.98e-06	6.5e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PTEN—lung cancer	4.97e-06	6.49e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CD—lung cancer	4.97e-06	6.48e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CD—lung cancer	4.95e-06	6.47e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—SRC—lung cancer	4.95e-06	6.47e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—KRAS—lung cancer	4.94e-06	6.45e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—EP300—lung cancer	4.92e-06	6.42e-05	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—PIK3CA—lung cancer	4.92e-06	6.42e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—ALB—lung cancer	4.89e-06	6.38e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—KRAS—lung cancer	4.86e-06	6.35e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling by GPCR—AKT1—lung cancer	4.85e-06	6.33e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—VEGFA—lung cancer	4.82e-06	6.3e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CXCL8—lung cancer	4.82e-06	6.29e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—HRAS—lung cancer	4.79e-06	6.25e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—STAT3—lung cancer	4.78e-06	6.23e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—NRAS—lung cancer	4.77e-06	6.22e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—EP300—lung cancer	4.74e-06	6.19e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—APOA1—lung cancer	4.66e-06	6.08e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP2E1—lung cancer	4.66e-06	6.08e-05	CbGpPWpGaD
Buspirone—HTR1A—GPCR downstream signaling—AKT1—lung cancer	4.65e-06	6.07e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CASP3—lung cancer	4.61e-06	6.02e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—SRC—lung cancer	4.61e-06	6.02e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IL2—lung cancer	4.6e-06	6.01e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—NQO1—lung cancer	4.6e-06	6.01e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—IL6—lung cancer	4.58e-06	5.98e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MAPK3—lung cancer	4.56e-06	5.96e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—PIK3CA—lung cancer	4.54e-06	5.93e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MDM2—lung cancer	4.52e-06	5.9e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—RAF1—lung cancer	4.51e-06	5.88e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—VEGFA—lung cancer	4.49e-06	5.86e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CCND1—lung cancer	4.49e-06	5.86e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—JUN—lung cancer	4.48e-06	5.84e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—PIK3CA—lung cancer	4.47e-06	5.83e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—ERBB2—lung cancer	4.46e-06	5.82e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MDM2—lung cancer	4.45e-06	5.81e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—STAT3—lung cancer	4.44e-06	5.8e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—MYC—lung cancer	4.44e-06	5.79e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—RAF1—lung cancer	4.44e-06	5.79e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—NRAS—lung cancer	4.43e-06	5.79e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MTOR—lung cancer	4.4e-06	5.74e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CB—lung cancer	4.4e-06	5.74e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—APOA1—lung cancer	4.39e-06	5.73e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—ERBB2—lung cancer	4.39e-06	5.73e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MMP9—lung cancer	4.36e-06	5.69e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—EGFR—lung cancer	4.34e-06	5.67e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—CDKN1A—lung cancer	4.34e-06	5.67e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PTEN—lung cancer	4.33e-06	5.65e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MTOR—lung cancer	4.33e-06	5.65e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CB—lung cancer	4.33e-06	5.65e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CB—lung cancer	4.32e-06	5.64e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTGS2—lung cancer	4.28e-06	5.58e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CG—lung cancer	4.25e-06	5.55e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MAPK3—lung cancer	4.25e-06	5.54e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CXCL8—lung cancer	4.23e-06	5.52e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling by GPCR—AKT1—lung cancer	4.23e-06	5.52e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—HRAS—lung cancer	4.2e-06	5.48e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CXCL8—lung cancer	4.16e-06	5.43e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—STK11—lung cancer	4.15e-06	5.42e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—HRAS—lung cancer	4.13e-06	5.4e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—EP300—lung cancer	4.13e-06	5.39e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—MYC—lung cancer	4.13e-06	5.39e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—KRAS—lung cancer	4.1e-06	5.35e-05	CbGpPWpGaD
Buspirone—DRD2—GPCR downstream signaling—AKT1—lung cancer	4.09e-06	5.33e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CASP3—lung cancer	4.05e-06	5.28e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—POMC—lung cancer	4.05e-06	5.28e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IL2—lung cancer	4.04e-06	5.28e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—EGFR—lung cancer	4.04e-06	5.27e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—IL6—lung cancer	4.02e-06	5.25e-05	CbGpPWpGaD
Buspirone—HTR2A—GPCR downstream signaling—AKT1—lung cancer	4.02e-06	5.25e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—SRC—lung cancer	4.02e-06	5.24e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CG—lung cancer	4.01e-06	5.23e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CASP3—lung cancer	3.98e-06	5.2e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IL2—lung cancer	3.98e-06	5.19e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—IL6—lung cancer	3.96e-06	5.16e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—CREBBP—lung cancer	3.94e-06	5.15e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CCND1—lung cancer	3.94e-06	5.14e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—JUN—lung cancer	3.93e-06	5.13e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—VEGFA—lung cancer	3.91e-06	5.11e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CCND1—lung cancer	3.88e-06	5.06e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—STAT3—lung cancer	3.87e-06	5.06e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—JUN—lung cancer	3.87e-06	5.05e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—NRAS—lung cancer	3.86e-06	5.04e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GSTP1—lung cancer	3.84e-06	5.01e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MMP9—lung cancer	3.83e-06	4.99e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—KRAS—lung cancer	3.82e-06	4.98e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—POMC—lung cancer	3.81e-06	4.98e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—CDKN1A—lung cancer	3.81e-06	4.97e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PTEN—lung cancer	3.8e-06	4.96e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—PIK3CA—lung cancer	3.77e-06	4.92e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MMP9—lung cancer	3.76e-06	4.91e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—CDKN1A—lung cancer	3.75e-06	4.9e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PTEN—lung cancer	3.74e-06	4.88e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CD—lung cancer	3.74e-06	4.88e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CAT—lung cancer	3.74e-06	4.88e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PTEN—lung cancer	3.73e-06	4.87e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—CREBBP—lung cancer	3.71e-06	4.85e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling by GPCR—AKT1—lung cancer	3.71e-06	4.84e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MAPK3—lung cancer	3.7e-06	4.83e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—ALB—lung cancer	3.69e-06	4.82e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling by GPCR—AKT1—lung cancer	3.65e-06	4.76e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—TP53—lung cancer	3.65e-06	4.76e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—PIK3CA—lung cancer	3.64e-06	4.75e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ABCB1—lung cancer	3.63e-06	4.74e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EP300—lung cancer	3.63e-06	4.73e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—MYC—lung cancer	3.6e-06	4.7e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—TYMS—lung cancer	3.57e-06	4.66e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EP300—lung cancer	3.57e-06	4.66e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—EP300—lung cancer	3.56e-06	4.64e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—GSTM1—lung cancer	3.53e-06	4.6e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—SRC—lung cancer	3.53e-06	4.6e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CD—lung cancer	3.52e-06	4.6e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—EGFR—lung cancer	3.52e-06	4.6e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—PIK3CA—lung cancer	3.51e-06	4.58e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—HRAS—lung cancer	3.49e-06	4.55e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—ALB—lung cancer	3.48e-06	4.54e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—SRC—lung cancer	3.47e-06	4.53e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—VEGFA—lung cancer	3.43e-06	4.48e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—STAT3—lung cancer	3.4e-06	4.44e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—NRAS—lung cancer	3.39e-06	4.43e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—TP53—lung cancer	3.39e-06	4.43e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—VEGFA—lung cancer	3.38e-06	4.41e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—STAT3—lung cancer	3.35e-06	4.37e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CYP1A1—lung cancer	3.34e-06	4.37e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—NRAS—lung cancer	3.34e-06	4.36e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—IL6—lung cancer	3.34e-06	4.35e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—KRAS—lung cancer	3.33e-06	4.34e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ERCC2—lung cancer	3.32e-06	4.33e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CB—lung cancer	3.26e-06	4.25e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MAPK3—lung cancer	3.25e-06	4.24e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—HRAS—lung cancer	3.24e-06	4.23e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTGS2—lung cancer	3.23e-06	4.21e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MAPK3—lung cancer	3.2e-06	4.17e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—MYC—lung cancer	3.16e-06	4.12e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—MYC—lung cancer	3.11e-06	4.06e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—IL6—lung cancer	3.1e-06	4.05e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—EGFR—lung cancer	3.09e-06	4.03e-05	CbGpPWpGaD
Buspirone—HTR2B—Signaling Pathways—AKT1—lung cancer	3.08e-06	4.02e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CB—lung cancer	3.07e-06	4.01e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—PIK3CA—lung cancer	3.06e-06	3.99e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTGS2—lung cancer	3.04e-06	3.97e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—EGFR—lung cancer	3.04e-06	3.97e-05	CbGpPWpGaD
Buspirone—CYP3A7—Metabolism—AKT1—lung cancer	2.97e-06	3.88e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—TP53—lung cancer	2.96e-06	3.86e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—KRAS—lung cancer	2.92e-06	3.81e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—KRAS—lung cancer	2.87e-06	3.75e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—APOA1—lung cancer	2.87e-06	3.75e-05	CbGpPWpGaD
Buspirone—DRD3—Signaling Pathways—AKT1—lung cancer	2.86e-06	3.74e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—HRAS—lung cancer	2.83e-06	3.69e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PTEN—lung cancer	2.82e-06	3.67e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—IL6—lung cancer	2.71e-06	3.53e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—EP300—lung cancer	2.68e-06	3.5e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—PIK3CA—lung cancer	2.68e-06	3.5e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PTEN—lung cancer	2.65e-06	3.46e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—PIK3CA—lung cancer	2.64e-06	3.45e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—PIK3CA—lung cancer	2.63e-06	3.44e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CG—lung cancer	2.62e-06	3.42e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—TP53—lung cancer	2.6e-06	3.39e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—TP53—lung cancer	2.55e-06	3.33e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—EP300—lung cancer	2.53e-06	3.3e-05	CbGpPWpGaD
Buspirone—HTR1A—Signaling Pathways—AKT1—lung cancer	2.5e-06	3.26e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—POMC—lung cancer	2.49e-06	3.25e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—HRAS—lung cancer	2.48e-06	3.24e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—HRAS—lung cancer	2.44e-06	3.19e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—CREBBP—lung cancer	2.43e-06	3.17e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—IL6—lung cancer	2.38e-06	3.1e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—IL6—lung cancer	2.34e-06	3.05e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CD—lung cancer	2.3e-06	3.01e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—ALB—lung cancer	2.27e-06	2.97e-05	CbGpPWpGaD
Buspirone—DRD2—Signaling Pathways—AKT1—lung cancer	2.19e-06	2.86e-05	CbGpPWpGaD
Buspirone—HTR2A—Signaling Pathways—AKT1—lung cancer	2.16e-06	2.81e-05	CbGpPWpGaD
Buspirone—CYP3A5—Metabolism—AKT1—lung cancer	2.15e-06	2.81e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CB—lung cancer	2.01e-06	2.62e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTGS2—lung cancer	1.99e-06	2.6e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—PIK3CA—lung cancer	1.99e-06	2.59e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—PIK3CA—lung cancer	1.87e-06	2.44e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PTEN—lung cancer	1.73e-06	2.26e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—EP300—lung cancer	1.65e-06	2.16e-05	CbGpPWpGaD
Buspirone—ABCB1—Metabolism—AKT1—lung cancer	1.62e-06	2.12e-05	CbGpPWpGaD
Buspirone—CYP2D6—Metabolism—AKT1—lung cancer	1.53e-06	2e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—PIK3CA—lung cancer	1.22e-06	1.6e-05	CbGpPWpGaD
Buspirone—CYP3A4—Metabolism—AKT1—lung cancer	1e-06	1.3e-05	CbGpPWpGaD
